Yes, your are correct as usual. It's really pathetic to see these longs fall for the same thing over and over again. I guess they won't learn until they are broke.
skidders, there's no way you have TA that advises this stock is ready to break higher. It's a broken stock and is in a clear downtrend! No technical charts could possibly advise buying this broken stock.
Henry, unfortunately I am like you. I listened to the pumpers when I should have been listening to the market. This stock is full of shorts and they do their homework and are right most of the time. Although this story sounds good, so do most biotech stories. You hit the nail right on the head; where are the big Pharma companies? Nobody is interested and there will be no partnership before one of these drugs is at least in Phase 3. So, I applaud your post and thank you for the insight. Nothing happening here. Thanks.....
cod, since the company just posted the position for a person to consummate the partnership, it's clear nothing is going to happen for at least 6 months to a year. Secondly, the stock would not be in full collapse mode if there were even a hint of a partnership. Finally, I get the 2 or 3 price range because it's just a simple fact that with all this negativity surrounding the stock, it has to return to it's low or even lower.
The stock just keeps trending lower and lower. It's quite apparent that there is no partnership lining up and no large drug companies interested in ARWRs' work yet. Maybe in a year or two, but not now. So, it's obvious the street is preparing for a secondary, which will send the stock back into the low 3's or hi 2's. The shorts appear to have this one right for at least the next year or so.
lambrusco, thanks for the info. I usually look at the market to help me decide what is happening with a company. The shorts are clearly all over this company and they typically do their homework. I'm inclined to think ARWR is a good short from here, given the evidence. They are running out of money and all their trials appear to be pushed back into 2017, and that's even according to some of the pumpers. I believe given all this new information that it's probably best to sell ARWR at this point and put on a protected short position because there isn't anything happening for another year or so. It's ashame because this looks promising, but they are too far away from anything happening and nobody is going to buy a company so far away from any meaningful results.
thanks crisp, I got caught up in all the positive comments by the pumpers. I should have known something was wrong as the stock is down almost every single day. I didn't realize we had now been passed by ALNY and others. Worse yet, no partnership possible until late 2017? They can't possibly survive that long. This now looks like a good short given your insight. Appreciate the help. I knew this looked too good to be true and was wondering why the smart money is selling and shorting. Now I know. Thanks again.
This doesn't sound good. I though we just determined last week that ARWR was ahead of ALNY in all respects. Now, you're saying ALNY has blow right past ARWR? Why the sudden change. No wonder ARWR suddenly collapsed. Did this news just come out?
Just what were you waiting to hear? You think he was going to say oh, and by the way, we have three companies that we're in discussions with who want to partner with us? Get real. He can't say a thing and he didn't. Like I said, nothing comes this easy.....shorts....
This looks way to easy for the shorts and I believe we are going to get some kind of very positive financing or partnership that nobody will be expecting. Seen this kind of set-up too many times. It's never this easy.....shorts.....
He's started to created some very positive momentum over the past few months. To do something to hurt investors at this point would set him and the stock back severely. Something tells me he won't let that happen and we'll get some more positives from the conference call.
I guess the money issue will be in full focus as this stock is getting pummeled in a great market. One can only come up with one explanation, and that's the money issue. It looks like this CEO won't be able to keep his word when he said they don't need cash in a hurry and they won't be affecting shareholders if they do raise cash. Shorts are telling us he will likely be going back on his word tonight.
See if the news is as good as the presentation last week. You can't keep getting tremendous news and not have the stock move higher. Sooner or later someone will have to recognize the value of this company.
M&A activity and partnerships have been picking up dramatically in the last week or two. I'm sure ARWR has to be a prime target of many.
There has to be a huge number of them signed by now, isn't there? The CEO of VHC himself said they had contracts in waiting. It must have been real easy for IP Value to get them signed.
Last week's announcement of Pfizer and Wave teaming up on RNAi technology should put a rush on someone partnering with ARWR. I don't think there's any doubt this now has to happen quickly as the big companies don't want to get shout out of this breakthrough technology.
VHC obviously has products and technology that nobody wants. They can't even give the junk away. AAPL should sue VHC for harassment and defamation. Let's hope they do and put this patent troll where it belongs....out of business.
Yes, you have to be pathetically naive to believe VHC will ever get a dime from AAPL and survive. There's not even a remote chance. The stock price says it all